Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alireza Talebzadeh"'
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology, Vol 47, Iss 1, Pp 4248-4256 (2019)
Brucellosis is one of the most common and important diseases between humans and animals. Herein, we developed a nanovaccine against Brucella melitensis based on oligopolysaccharide (OPS) antigen and PLGA nanoparticles. The conjugation of extracted OP
Externí odkaz:
https://doaj.org/article/ee1297e25e5e412ba975924feeaf00da
Publikováno v:
Journal of Advanced Pharmaceutical Technology & Research, Vol 7, Iss 3, Pp 70-74 (2016)
Considering the importance of accreditation for hospital pharmacies, this study was to determine the challenges of medication management in hospital pharmacies affiliated with Shiraz University of Medical Sciences, Iran. The study was a mix-method re
Externí odkaz:
https://doaj.org/article/1c89ab2f5fe348b787cbd098782dd586
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology. 47:4248-4256
Brucellosis is one of the most common and important diseases between humans and animals. Herein, we developed a nanovaccine against Brucella melitensis based on oligopolysaccharide (OPS) antigen and PLGA nanoparticles. The conjugation of extracted OP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b05b302bafafaa4ce80cf84de76caa28
https://doi.org/10.1080/21691401.2019.1687490
https://doi.org/10.1080/21691401.2019.1687490
Publikováno v:
Journal of Advanced Pharmaceutical Technology & Research
Journal of Advanced Pharmaceutical Technology & Research, Vol 7, Iss 3, Pp 70-74 (2016)
Journal of Advanced Pharmaceutical Technology & Research, Vol 7, Iss 3, Pp 70-74 (2016)
Considering the importance of accreditation for hospital pharmacies, this study was to determine the challenges of medication management in hospital pharmacies affiliated with Shiraz University of Medical Sciences, Iran. The study was a mix-method re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3adbea164d7de02f52723201dbe0146b
http://europepmc.org/articles/PMC4932808
http://europepmc.org/articles/PMC4932808